Ilkka T Harvima Selected Research

Vascular Skin Diseases

1/2022	Sequential Increase in Complement Factor I, iC3b, and Cells Expressing CD11b or CD14 in Cutaneous Vasculitis.
10/2016	Complement C3 is expressed by mast cells in cutaneous vasculitis and is degraded by chymase.
12/2015	Mast cell tryptase and chymase in the progress of cutaneous vasculitis.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Ilkka T Harvima Research Topics

Disease

7	Inflammation (Inflammations) 12/2017 - 04/2003
6	Psoriasis (Pustulosis Palmaris et Plantaris) 03/2017 - 10/2006
4	Squamous Cell Carcinoma (Epidermoid Carcinoma) 01/2021 - 02/2008
4	Carcinoma (Carcinomatosis) 01/2019 - 02/2008
4	type 2C Congenital disorder of glycosylation 12/2017 - 11/2015
3	Vascular Skin Diseases 01/2022 - 12/2015
3	Hypersensitivity (Allergy) 01/2022 - 12/2008
3	Melanoma (Melanoma, Malignant) 01/2022 - 12/2015
3	Vasculitis (Vasculitides) 01/2022 - 12/2015
3	Skin Neoplasms (Skin Cancer) 01/2021 - 11/2015
3	Basal Cell Carcinoma (Rodent Ulcer) 01/2019 - 09/2007
3	Atopic Dermatitis (Atopic Eczema) 04/2015 - 04/2003
2	Neoplasms (Cancer) 01/2022 - 09/2011
2	Carcinogenesis 01/2021 - 09/2007
2	Mastocytosis 01/2021 - 08/2010
2	Major Depressive Disorder (Major Depressive Disorders) 01/2016 - 01/2012
2	Asthma (Bronchial Asthma) 01/2012 - 08/2010
1	Purpura 01/2022
1	Cutaneous Malignant Melanoma 01/2022
1	Erysipelas 01/2022
1	Pain (Aches) 01/2018
1	Neurogenic Inflammation 01/2018
1	Pruritus (Itching) 01/2018
1	Mast-Cell Sarcoma 12/2017
1	Actinic Keratosis 03/2017
1	Cutaneous Leukocytoclastic Vasculitis (Hypersensitivity Angiitis) 10/2016
1	Nevus (Nevi) 12/2015
1	Dysplastic Nevus Syndrome (Dysplastic Nevus) 12/2015
1	Lymphatic Metastasis 12/2015
1	B-Cell Lymphoma (Lymphoma, B Cell) 09/2014
1	Hyperplasia 10/2008
1	Cold Urticaria 01/2007
1	Skin Diseases (Skin Disease) 10/2006
1	Blister (Bulla) 06/2004
1	Breast Neoplasms (Breast Cancer) 06/2004
1	Fibrosis (Cirrhosis) 06/2004
1	Eczema 04/2003
1	Leg Ulcer 10/2002
1	Wounds and Injuries (Trauma) 10/2002

Drug/Important Bio-Agent (IBA)

8	Chymases (Chymase)IBA 01/2022 - 10/2008
7	Tryptases (Tryptase)IBA 01/2022 - 10/2008
4	Serine Proteases (Serine Protease)IBA 01/2021 - 09/2011
4	Histamine (Histamine Dihydrochloride)FDA Link 10/2016 - 01/2007
3	Complement C3 (C3 Complement)IBA 01/2022 - 10/2016
3	Proteins (Proteins, Gene)FDA Link 01/2021 - 09/2007
3	NeuropeptidesIBA 01/2018 - 04/2003
2	EnzymesIBA 12/2015 - 11/2015
2	CytokinesIBA 10/2008 - 04/2003
2	Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA 02/2008 - 09/2007
2	CD30 LigandIBA 09/2007 - 10/2006
1	Complement C3b (C3bi)IBA 01/2022
1	Complement Factor I (C3b Inactivator)IBA 01/2022
1	Penicillin G (Benzylpenicillin)FDA LinkGeneric 01/2022
1	Penicillin V (Phenoxymethylpenicillin)FDA LinkGeneric 01/2022
1	Penicillins (Penicillin)FDA Link 01/2022
1	Peptide Hydrolases (Proteases)FDA Link 01/2022
1	Complement C3cIBA 01/2019
1	AntibodiesIBA 01/2019
1	Vitamin D3 24-HydroxylaseIBA 12/2017
1	Calcitriol Receptors (Calcitriol Receptor)IBA 12/2017
1	CD40 Ligand (CD40L)IBA 03/2017
1	Immunoglobulin A (IgA)IBA 10/2016
1	Complement System Proteins (Complement)IBA 10/2016
1	Immunoglobulin M (IgM)IBA 10/2016
1	Immunoglobulin G (IgG)IBA 10/2016
1	Trypsin InhibitorsIBA 06/2016
1	ThymidineIBA 06/2016
1	MitogensIBA 01/2016
1	ParaffinIBA 12/2015
1	Cholecalciferol (Vitamin D3)FDA Link 11/2015
1	25-Hydroxyvitamin D3 1-alpha-Hydroxylase (25 Hydroxyvitamin D3 1 alpha Hydroxylase)IBA 11/2015
1	Interleukin-33IBA 05/2015
1	Interleukin-6 (Interleukin 6)IBA 04/2015
1	InterleukinsIBA 04/2015
1	Ion Channels (Ion Channel)IBA 09/2014
1	Corticotropin-Releasing HormoneIBA 03/2012
1	Non-Steroidal Anti-Inflammatory Agents (NSAIDs)IBA 01/2012
1	Interleukin-5 (Interleukin 5)IBA 01/2012
1	Antidepressive Agents (Antidepressants)IBA 01/2012
1	Protease Inhibitors (Protease Inhibitor)IBA 09/2011
1	AntigensIBA 09/2011
1	ABT-737IBA 08/2010
1	LigandsIBA 10/2008
1	Histamine Antagonists (Antihistamines)IBA 01/2007
1	montelukast (Singulair)FDA Link 01/2007
1	IceIBA 01/2007
1	Cetirizine (Zyrtec)FDA LinkGeneric 01/2007
1	Leukotriene C4IBA 01/2007
1	Leukotriene Antagonists (Leukotriene Receptor Antagonists)IBA 01/2007
1	ChemokinesIBA 10/2006
1	CollagenIBA 06/2004
1	Substance PIBA 04/2003
1	Calcitonin Gene-Related PeptideIBA 04/2003
1	Vasoactive Intestinal Peptide (VIP (Vasoactive Intestinal Peptide))IBA 04/2003

Therapy/Procedure

1	Therapeutics 01/2022
1	Radiotherapy 06/2004
1	Skin Transplantation (Skin Grafting) 10/2002